Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Angiotensin receptor blockers were associated with worse outcomes in patients with celiac disease ...
Please provide your email address to receive an email when new articles are posted on . Compared with ACE inhibitors, beta-blockers, calcium channel blockers, diuretic and no treatment at all, ...
Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...
In a recent study published in the BMJ, researchers conducted a phase three, multicenter, randomized controlled trial to evaluate the effect of using angiotensin receptor blockers that disrupt the ...
Angiotensin receptor blockers exhibited potential neuroprotective properties for reducing Parkinson disease (PD) risk in patients with newly diagnosed hypertension. A statistically significant ...
Hypertension control is critical to prevent stroke. With several clinical trials conducted over the last decade, it seems that the use of an angiotensin-modulating antihypertensive agent conveys ...
Losartan may help stop the epileptic process in certain patients with hypertension. An observational study that analyzed medical records of 2.26 million patients with hypertension found a roughly 30% ...
A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3). This is an ASCO Meeting Abstract ...
Everyday Health on MSN
Novel targeted therapies for IgAN: What you need to know
Explore novel therapies for IgA nephropathy that target inflammation and antibody production. Learn how these advancements ...
Researchers found that the incidence of epilepsy was reduced with use of ARBs vs ACEs, β-blockers, and a combination of other antihypertensive classes. HealthDay News — For patients with hypertension, ...
Scientists have discovered a new generation of angiotensin receptor blockers that may be used to treat coronavirus disease 2019 (COVID-19). In silico docking and molecular dynamics studies have shown ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results